Cargando…
Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equa...
Autores principales: | Nagayama, Izumi, Masuda, Takahiro, Nakagawa, Saki, Murakami, Takuya, Ohara, Ken, Matsuoka, Ryo, Kobayashi, Takahisa, Maeshima, Akito, Akimoto, Tetsu, Saito, Osamu, Muto, Shigeaki, Nagata, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599930/ https://www.ncbi.nlm.nih.gov/pubmed/30713322 http://dx.doi.org/10.2169/internalmedicine.2174-18 |
Ejemplares similares
-
Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid Retention
por: Masuda, Takahiro, et al.
Publicado: (2016) -
Hemolytic Uremic Syndrome: An Increasingly Recognized Public Health
Problem
por: Murakami, Takuya, et al.
Publicado: (2018) -
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease
por: Ohara, Ken, et al.
Publicado: (2020) -
Nephrotic Syndrome and a Retroperitoneal Mass: A Case Report of a Patient with Recurrent Invasive Thymoma
por: Myoga, Hiroaki, et al.
Publicado: (2017) -
Pleuroperitoneal Communication and Ovarian Cancer Complicating Peritoneal Dialysis: A Case Report of a Patient with End-Stage Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2017)